Physician profile
Patrick Murt
NPI 1457735870
$1,511.21
in general payments reported to CMS, 2019-2025
17 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $376 · 2023: $208 · 2024: $497 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $419.06 | 2021-2024 | Farxiga, Brilinta, Lokelma |
| Getinge USA Sales, LLC | $135.57 | 2022-2023 | Acrobat-I Stabilizer |
| Medical Device Business Services, INC. | $117.64 | 2024 | Vistaseal, Stratafix |
| Baxter Healthcare | $104.79 | 2021-2024 | Preveleak, Coseal |
| Medtronic, INC. | $103.16 | 2022-2025 | Freestyle, Avalus, Corevalve Evolut R |
| Atricure, INC. | $92.90 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.90 | 2023-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.41 | 2021-2025 | Lifevest |
| Abiomed | $70.52 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $66.55 | 2021-2024 | Eliquis |
| Arthrex, INC. | $59.54 | 2024 | |
| Abbott Laboratories | $44.21 | 2024-2025 | Esprit |
| Edwards Lifesciences Corporation | $36.79 | 2025 | Mitris Resilia Mitral Valve |
| Janssen Pharmaceuticals, INC | $32.26 | 2021 | |
| Pfizer INC. | $30.56 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $19.60 | 2025 | Giapreza |
| Becton, Dickinson and Company | $17.75 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Murt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.